T. Rowe Price Associates, Inc. 13D and 13G filings for Elanco Animal Health Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Elanco Animal Health Incorporated ELAN | T. Rowe Price Associates, Inc. | 18,846,927 4.000% | -15,827,381 (-45.65%) | Filing |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | Elanco Animal Health Incorporated ELAN | T. Rowe Price Associates, Inc. | 34,674,308 7.300% | -12,986,687 (-27.25%) | Filing |
| 2021-09-10 1:36 pm Purchase | 2021-08-31 | 13G | Elanco Animal Health Incorporated ELAN | T. Rowe Price Associates, Inc. | 47,660,995 10.000% | 6,004,414 (+14.41%) | Filing |
| 2021-02-16 12:24 pm Purchase | 2020-12-31 | 13G | Elanco Animal Health Incorporated ELAN | T. Rowe Price Associates, Inc. | 41,656,581 8.800% | 251,004 (+0.61%) | Filing |
| 2020-02-10 3:50 pm Purchase | 2020-01-31 | 13G | Elanco Animal Health Incorporated ELAN | T. Rowe Price Associates, Inc. | 41,405,577 10.300% | 7,972,350 (+23.85%) | Filing |
| 2020-02-10 09:38 am Sale | 2019-12-31 | 13G | Elanco Animal Health Incorporated ELAN | T. Rowe Price Associates, Inc. | 33,433,227 8.900% | -5,245,676 (-13.56%) | Filing |